European Journal of Surgical Oncology
Volume 35, Issue 3 , Pages 258-263 , March 2009

Locoregional recurrence in breast carcinoma patients

  • E. Yıldırım

      Affiliations

    • Corresponding Author InformationKonutkent-2, A-4 Blok 44, Cayyolu 06530, Ankara, Turkey. Tel.: +90 312 240 2951; fax: +90 312 345 4979.

,Accepted 9 June 2008.

References 

  1. Jager JJ, Volovics L, Schouten LJ, et al. Locoregional recurrences after mastectomy in breast cancer: Prognostic factors and implications for postoperative irradiation. Radiother Oncol. 1999;50:267–275
  2. Jatoi I, Proschan MA. Randomized trials of breast-conserving therapy versus mastectomy for primary breast cancer. A pooled analysis of updated results. Am J Clin Oncol. 2005;28:289–294
  3. Buchanan CL, Dorn PL, Fey J, et al. Locoregional recurrence after mastectomy. J Am Coll Surg. 2006;203:469–474
  4. Livi L, Saieva C, Detti B, et al. Loco-regional recurrence in 2064 patients with breast cancer treated with mastectomy without adjuvant radiotherapy. Eur J Surg Oncol. 2007;33:977–981
  5. Carreno G, del Casar JM, Corte MD, et al. Local recurrence after mastectomy for breast cancer: Analysis of clinicopathological, biological and prognostic characteristics. Breast Cancer Res Treat. 2007;102:61–73
  6. Recht A, Gray R, Davidson NE, et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol. 1999;17:1689–1700
  7. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia Randomized Trial. J Natl Cancer Inst. 2005;97:116–126
  8. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b trial. N Engl J Med. 1997;337:949–955
  9. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high risk postmenopausal breast cancer patients given adjuvant tamoxifen. Danish Breast Cancer Cooperative Group 82c randomised trial. Lancet. 1999;353:1641–1648
  10. Early Breast Cancer Trialists’ Collaborative Group. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;356:2087–2106
  11. Chung CS, Harris JR. Post-mastectomy radiation therapy: Translating local benefits into improved survival. Breast. 2007;16:S78–S83
  12. Cox DR. Regression models and life tables. J R Stat Soc. 1972;B34:187–220
  13. Truong PT, Woodward WA, Thames HD, et al. The ratio of positive to excised nodes identifies high-risk subsets and reduces inter-institutional differences in locoregional recurrence risk estimates in breast cancer patients with 1-3 positive nodes: An analysis of prospective data from British Columbia and the M.D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys. 2007;68:59–65
  14. Cheng SH, Horng CF, Clarke JL, et al. Prognostic index score and clinical prediction model of local regional recurrence after mastectomy in breast cancer patients. Int J Radiat Oncol Biol Phys. 2006;64:1401–1409
  15. Katz A, Strom EA, Buchholz TA, et al. Locoregional recurrence patterns after mastectomy and doxorubicine-based chemotherapy: Implications for postoperative irradiation. J Clin Oncol. 2000;18:2817–2827
  16. Karlsson P, Cole BF, Price KN, et al. The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol. 2007;25:2019–2026
  17. Kyndi M, Sorensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26:1419–1426
  18. Killander F, Anderson H, Ryden S, et al. Radiotherapy and tamoxifen after mastectomy in post menopausal women-20 year follow-up of the South Sweden Breast Cancer group randomised trial SSBCG II:I. Eur J Cancer. 2007;43:2100–2108
  19. Garg AK, Oh JL, Oswald MJ, et al. Effect of postmastectomy radiotherapy in patients <35 years old with stage II-III breast cancer treated with doxorubicine-based neoadjuvant chemotherapy and mastectomy. Int J Radiat Oncol Biol Phys. 2007;69:1478–1483
  20. Chan A, Pintilie M, Vallis K, Girourd C, Goss P. Breast cancer in women ≤35 years: Review of 1002 cases from a single institution. Ann Oncol. 2000;11:1255–1262
  21. Kroman N, Holtveg H, Wohlfahrt J, et al. Effect of breast-conserving therapy versus radical mastectomy on prognosis for young women with breast carcinoma. Cancer. 2004;100:688–693
  22. Early Breast Cancer Trialists’ Collaborative Group. Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet. 2005;365:1687–1717
  23. Morrogh M, Borgen PI, King TA. The importance of local control in early stage breast cancer: A historical review and a discussion of ongoing issues. Ann Surg Oncol. 2007;14:3310–3320
  24. Jagsi R, Raad AR, Goldberg S, et al. Locoregional recurrence rates and prognostic factors for failure in node negative patients treated with mastectomy: implications for postmastectomy radiation. Int J Radiat Oncol Biol Phys. 2005;62:1035–1039
  25. Truong PT, Lesperance M, Culhaci A, et al. Patient subsets with T1-T2, node negative breast cancer at high locoregional recurrence risk after mastectomy. Int J Radiat Oncol Biol Phys. 2005;62:175–182
  26. Yildirim E, Berberoglu U. Can a subgroup of node negative breast carcinoma patients with T1-2 tumor who may benefit from postmastectomy radiotherapy be identified?. Int J Radiat Oncol Biol Phys. 2007;68:1024–1029
  27. Yildirim E, Berberoglu U. Local recurrence in breast carcinoma patients T1-2 and 1-3 positive nodes: Indications for radiotherapy. Eur J Surg Oncol. 2007;33:28–32
  28. Overgaard M, Nielsen HM, Overgaard J. Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials. Radiother Oncol. 2007;82:247–253
  29. Gentilini O, Botteri E, Rotmensz N, et al. Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institution. Ann Oncol. 2007;18:1342–1347

PII: S0748-7983(08)00206-0

doi: 10.1016/j.ejso.2008.06.010

European Journal of Surgical Oncology
Volume 35, Issue 3 , Pages 258-263 , March 2009

Article Tools